NCT00674154

Effect of Vitamin D Treatment in Primary Hyperparathyroidism

• Status: Completed
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 46 (actual)
• Sponsor: University of Aarhus · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The primary aim of the study is to assess whether 6-months of vitamin D supplements can decrease PTH compared with placebo treatment in primary hyperparathyroidism.

Detailed description

The study investigates effects and safety of six months of vitamin D supplementation before and after surgery in primary hyperparathyroidism. Effects are assessed as changes in calcium homeostasis, bone metabolism, quality of life, and muscle strength and function.

Conditions

• Vitamin D Deficiency
• Primary Hyperparathyroidism
• Hypercalcemia

Interventions

Type	Name	Description
DRUG	Cholecalciferol	2800 IE daily in 52 weeks

Timeline

• Start date: 2008-05-01
• Primary completion: 2013-08-01
• Completion: 2013-08-01
• First posted: 2008-05-07
• Last updated: 2013-11-18
• Results posted: 2013-10-16

Locations

1 site across 1 country: Denmark